+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Postpartum Depression Treatment Market Research Report by Treatment Type (Antidepressant Drugs and Psychotherapy), Distribution, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 247 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5639504
UP TO OFF until Mar 31st 2023
The Global Postpartum Depression Treatment Market size was estimated at USD 876.69 million in 2022, USD 948.54 million in 2023, and is projected to grow at a CAGR of 8.67% to reach USD 1,705.58 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Postpartum Depression Treatment Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Postpartum Depression Treatment Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Postpartum Depression Treatment Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Postpartum Depression Treatment Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Postpartum Depression Treatment Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment Type, the market is studied across Antidepressant Drugs and Psychotherapy. The Antidepressant Drugs is further studied across Bupropion, Desipramine, Escitalopram, Paroxetine, Sertraline, Tranylcypromine, and Trimipramine. The Psychotherapy is further studied across Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Psychodynamic Psychotherapy, and Solution-Focused Brief Psychotherapy.
  • Based on Distribution, the market is studied across Drug Stores, E-Commerce, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Postpartum Depression Treatment Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Postpartum Depression Treatment Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Postpartum Depression Treatment Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Postpartum Depression Treatment Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Postpartum Depression Treatment Market, including Accord Healthcare Ltd., Alvogen Group Inc, Anikem Laboratories, AstraZeneca PLC, Bausch Health Companies Inc., Cipla Limited, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck A/S, Intas Pharmaceuticals Ltd., Lupin Ltd., Mylan N.V., Novartis AG, Pfizer, Inc., Sage Therapeutics, Inc., Sebela Pharmaceuticals, Inc., Shionogi & Company, Limited, Solvay S.A., Sumika Polymer Compounds (EU) Ltd, Sun Pharmaceutical Industries Limited, and Teva Pharmaceuticals Industries Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Postpartum Depression Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Postpartum Depression Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Postpartum Depression Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Postpartum Depression Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Postpartum Depression Treatment Market?
6. What is the market share of the leading vendors in the Global Postpartum Depression Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Postpartum Depression Treatment Market?
Frequently Asked Questions about the Global Postpartum Depression Treatment Market

What is the estimated value of the Global Postpartum Depression Treatment Market?

The Global Postpartum Depression Treatment Market was estimated to be valued at $876.69 Million in 2022.

What is the growth rate of the Global Postpartum Depression Treatment Market?

The growth rate of the Global Postpartum Depression Treatment Market is 8.6%, with an estimated value of $1705.58 Million by 2030.

What is the forecasted size of the Global Postpartum Depression Treatment Market?

The Global Postpartum Depression Treatment Market is estimated to be worth $1705.58 Million by 2030.

Who are the key companies in the Global Postpartum Depression Treatment Market?

Key companies in the Global Postpartum Depression Treatment Market include Accord Healthcare Ltd., Alvogen Group Inc, Anikem Laboratories, AstraZeneca PLC, Bausch Health Companies Inc., Cipla Limited, Eli Lilly and Company, GlaxoSmithKline PLC and Intas Pharmaceuticals Ltd..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalences of mood disorder associated with pregnancy across the globe
5.1.1.2. Growing demand for antidepressant medication and talk therapies
5.1.1.3. Increasing approvals from regulatory bodies for PPD treatment
5.1.2. Restraints
5.1.2.1. Limited availability of medical professionals
5.1.3. Opportunities
5.1.3.1. Growing availability of telehealth and telemedicine
5.1.3.2. Rising research activities for treatment of Postpartum Depression Treatment (PPD) in emerging markets
5.1.4. Challenges
5.1.4.1. Issues related to product recalls
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Postpartum Depression Treatment Market, by Treatment Type
6.1. Introduction
6.2. Antidepressant Drugs
6.3.1. Bupropion
6.3.2. Desipramine
6.3.3. Escitalopram
6.3.4. Paroxetine
6.3.5. Sertraline
6.3.6. Tranylcypromine
6.3.7. Trimipramine
6.3. Psychotherapy
6.4.1. Cognitive Behavioral Therapy
6.4.2. Interpersonal Psychotherapy
6.4.3. Psychodynamic Psychotherapy
6.4.4. Solution-Focused Brief Psychotherapy

7. Postpartum Depression Treatment Market, by Distribution
7.1. Introduction
7.2. Drug Stores
7.3. E-Commerce
7.4. Hospital Pharmacies
7.5. Retail Pharmacies

8. Americas Postpartum Depression Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Postpartum Depression Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Postpartum Depression Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Accord Healthcare Ltd.
12.2. Alvogen Group Inc
12.3. Anikem Laboratories
12.4. AstraZeneca PLC
12.5. Bausch Health Companies Inc.
12.6. Cipla Limited
12.7. Eli Lilly and Company
12.8. GlaxoSmithKline PLC
12.9. H. Lundbeck A/S
12.10. Intas Pharmaceuticals Ltd.
12.11. Lupin Ltd.
12.12. Mylan N.V.
12.13. Novartis AG
12.14. Pfizer, Inc.
12.15. Sage Therapeutics, Inc.
12.16. Sebela Pharmaceuticals, Inc.
12.17. Shionogi & Company, Limited
12.18. Solvay S.A.
12.19. Sumika Polymer Compounds (EU) Ltd
12.20. Sun Pharmaceutical Industries Limited
12.21. Teva Pharmaceuticals Industries Ltd.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET DYNAMICS
FIGURE 11. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY TREATMENT TYPE, 2030
FIGURE 15. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY BUPROPION, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DESIPRAMINE, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ESCITALOPRAM, 2018-2030 (USD MILLION)
FIGURE 19. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PAROXETINE, 2018-2030 (USD MILLION)
FIGURE 20. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SERTRALINE, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRANYLCYPROMINE, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRIMIPRAMINE, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
FIGURE 25. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 26. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHODYNAMIC PSYCHOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SOLUTION-FOCUSED BRIEF PSYCHOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
FIGURE 29. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 30. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION, 2030
FIGURE 31. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DRUG STORES, 2018-2030 (USD MILLION)
FIGURE 32. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
FIGURE 33. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
FIGURE 35. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 37. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 38. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 39. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 45. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 46. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 47. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 49. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 50. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 51. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 67. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 89. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 90. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY BUPROPION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY BUPROPION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY BUPROPION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DESIPRAMINE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DESIPRAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DESIPRAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ESCITALOPRAM, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ESCITALOPRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ESCITALOPRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PAROXETINE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PAROXETINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PAROXETINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SERTRALINE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SERTRALINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SERTRALINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRANYLCYPROMINE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRANYLCYPROMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRANYLCYPROMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRIMIPRAMINE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRIMIPRAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRIMIPRAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHODYNAMIC PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHODYNAMIC PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHODYNAMIC PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SOLUTION-FOCUSED BRIEF PSYCHOTHERAPY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SOLUTION-FOCUSED BRIEF PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SOLUTION-FOCUSED BRIEF PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DRUG STORES, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 70. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 86. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 87. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 89. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 95. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 96. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 113. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 123. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 124. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 125. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 126. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 127. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 129. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 130. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 132. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 133. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 135. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 137. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 139. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 140. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 141. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 142. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 143. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 150. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 152. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 153. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 154. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 156. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 157. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 158. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 178. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 186. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 187. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 188. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 189. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET RANKING, BY KEY PLAYER, 2022
TABLE 190. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 191. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 192. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET MERGER & ACQUISITION
TABLE 193. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 194. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 195. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET INVESTMENT & FUNDING
TABLE 196. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 197. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Accord Healthcare Ltd.
  • Alvogen Group Inc
  • Anikem Laboratories
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Cipla Limited
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Intas Pharmaceuticals Ltd.
  • Lupin Ltd.
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sage Therapeutics, Inc.
  • Sebela Pharmaceuticals, Inc.
  • Shionogi & Company, Limited
  • Solvay S.A.
  • Sumika Polymer Compounds (EU) Ltd
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceuticals Industries Ltd.

Methodology

Loading
LOADING...